MA28210A1 - Composition pharmaceutique contenant en association l'ubidecarenone, le dexpanthenol et le chlorhexidine ou leurs sels acceptables du point de vue pharmaceutique pour application cutanee - Google Patents
Composition pharmaceutique contenant en association l'ubidecarenone, le dexpanthenol et le chlorhexidine ou leurs sels acceptables du point de vue pharmaceutique pour application cutaneeInfo
- Publication number
- MA28210A1 MA28210A1 MA28854A MA28854A MA28210A1 MA 28210 A1 MA28210 A1 MA 28210A1 MA 28854 A MA28854 A MA 28854A MA 28854 A MA28854 A MA 28854A MA 28210 A1 MA28210 A1 MA 28210A1
- Authority
- MA
- Morocco
- Prior art keywords
- pharmaceutical composition
- ubidecarenone
- dexpanthenol
- chlorhexidine
- association
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 3
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 title abstract 2
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 title abstract 2
- 239000011703 D-panthenol Substances 0.000 title abstract 2
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 title abstract 2
- 235000004866 D-panthenol Nutrition 0.000 title abstract 2
- 229960003260 chlorhexidine Drugs 0.000 title abstract 2
- 235000017471 coenzyme Q10 Nutrition 0.000 title abstract 2
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 title abstract 2
- 229960003949 dexpanthenol Drugs 0.000 title abstract 2
- 229960004747 ubidecarenone Drugs 0.000 title abstract 2
- 239000000126 substance Substances 0.000 abstract 3
- 208000016583 Anus disease Diseases 0.000 abstract 2
- 206010002153 Anal fissure Diseases 0.000 abstract 1
- 208000009531 Fissure in Ano Diseases 0.000 abstract 1
- 230000001154 acute effect Effects 0.000 abstract 1
- 230000002421 anti-septic effect Effects 0.000 abstract 1
- 230000003078 antioxidant effect Effects 0.000 abstract 1
- 230000001684 chronic effect Effects 0.000 abstract 1
- 239000000645 desinfectant Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000035876 healing Effects 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Dispersion Chemistry (AREA)
- Dermatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05398003A EP1700597B1 (fr) | 2005-03-04 | 2005-03-04 | Composition pharmaceutique comprenant en association ubidecarenone, dexpanthenol et chlorhexidine ou un de ses sels pharmaceutiquement acceptables pour application cutanée |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA28210A1 true MA28210A1 (fr) | 2006-10-02 |
Family
ID=35601798
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA28854A MA28210A1 (fr) | 2005-03-04 | 2006-03-03 | Composition pharmaceutique contenant en association l'ubidecarenone, le dexpanthenol et le chlorhexidine ou leurs sels acceptables du point de vue pharmaceutique pour application cutanee |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1700597B1 (fr) |
| AT (1) | ATE458477T1 (fr) |
| BR (1) | BRPI0600799B8 (fr) |
| DE (1) | DE602005019533D1 (fr) |
| ES (1) | ES2341784T3 (fr) |
| MA (1) | MA28210A1 (fr) |
| PL (1) | PL1700597T3 (fr) |
| PT (1) | PT1700597E (fr) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2001275888A1 (en) * | 2000-07-11 | 2002-01-21 | Collaborative Technologies, Inc. | Methods for preparing high pressure/high shear dispersions containing waxes and other semi-solidds and oils |
| CN1470236A (zh) * | 2002-07-26 | 2004-01-28 | 武汉市第四医院 | 一种治疗痔疮和肛裂的多组分制剂 |
| CN1856294A (zh) * | 2003-08-25 | 2006-11-01 | 弗米克斯有限公司 | 渗透性药物泡沫 |
-
2005
- 2005-03-04 PT PT05398003T patent/PT1700597E/pt unknown
- 2005-03-04 DE DE602005019533T patent/DE602005019533D1/de not_active Expired - Lifetime
- 2005-03-04 AT AT05398003T patent/ATE458477T1/de not_active IP Right Cessation
- 2005-03-04 PL PL05398003T patent/PL1700597T3/pl unknown
- 2005-03-04 ES ES05398003T patent/ES2341784T3/es not_active Expired - Lifetime
- 2005-03-04 EP EP05398003A patent/EP1700597B1/fr not_active Expired - Lifetime
-
2006
- 2006-03-03 MA MA28854A patent/MA28210A1/fr unknown
- 2006-03-06 BR BRPI0600799-6 patent/BRPI0600799B8/pt active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| DE602005019533D1 (de) | 2010-04-08 |
| BRPI0600799B1 (pt) | 2019-07-23 |
| PT1700597E (pt) | 2010-06-01 |
| PL1700597T3 (pl) | 2010-07-30 |
| ATE458477T1 (de) | 2010-03-15 |
| BRPI0600799B8 (pt) | 2021-05-25 |
| ES2341784T3 (es) | 2010-06-28 |
| BRPI0600799A (pt) | 2007-05-15 |
| EP1700597B1 (fr) | 2010-02-24 |
| EP1700597A1 (fr) | 2006-09-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE339187T1 (de) | Verwendung von zusammensetzungen mit antiseptika und/oder die wundheilung fördernden wirkstoffen für den tieferen atemwegstrakt | |
| ATE361084T1 (de) | Topische pharmazeutische zusammensetzungen mit proanthocyanidinen, glycyrrhetinic säure und telmesteine zur behandlung von dermatitis | |
| EA200801492A1 (ru) | Фармацевтическое применение замещенных амидов | |
| EP1562897A4 (fr) | Inhibiteurs de beta-secretase phenylcarboxamide utilises dans le traitement de la maladie d'alzheimer | |
| CY1108794T1 (el) | Σπειροκυκλικα παραγωγα κυκλοεξανιου | |
| BRPI0508540A (pt) | composto, composição farmacêutica, e, uso de um composto | |
| DE602005021770D1 (de) | Indol-1-yl-essigsäurederivate | |
| BR0312000A (pt) | Compostos, composições farmacêuticas, método para o tratamento ou profilaxia de doenças, e, uso dos compostos | |
| BRPI0410979A (pt) | composto, composição farmacêutica, e, métodos para tratar uma doença em um animal mediada pela catepsina s e para tratar um paciente submetido a uma terapia | |
| ATE412646T1 (de) | Zur behandlung von schmerzen geeignete therapeutische mittel | |
| EA200601846A1 (ru) | Содержащие бензоксазины лекарственные комбинации для лечения заболеваний дыхательных путей | |
| BR112012030641A2 (pt) | métodos e composições para terapia farmacêutica oral | |
| EA200601091A1 (ru) | Водные суспензии циклесонида для аэрозольного распыления | |
| EP1852114A4 (fr) | PRÉPARATION CONTENANT DE L'ACIDE DIHOMO-(gamma)-LINOLÉNIQUE (DGLA) AU TITRE DE PRINCIPE ACTIF | |
| BR0316458A (pt) | Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, método para intensificar a cognição em um paciente saudável, e, uso de um composto | |
| NO20076405L (no) | Anvendelse av 24-nor-UDCA | |
| WO2004100893A3 (fr) | Methodes de traitement d'affections inflammatoires a l'aide de ct-3 ou de ses analogues | |
| ATE289805T1 (de) | Verwendung von antiseptika zur herstelllung von arzneimitteln zur prophylaxe und behandlung von infektionen und/ oder funktionellen gewebeumformungen im körperinneren | |
| AR045070A1 (es) | Preparados farmaceuticos topicos de acido ascorbico con efecto post-antimicotico | |
| EA200900269A1 (ru) | Лекарственные комбинации для лечения заболеваний дыхательных путей | |
| BR0116653A (pt) | Medicamento contendo uma poliamina como substância ativa | |
| AR032553A1 (es) | Derivados de alfa-amino-n-hidroxi-acetamida. | |
| ATE344662T1 (de) | Mittel enthaltend n-chlortaurin sowie dessen verwendung zur behandlung von schleimhautpolypen | |
| AR120931A1 (es) | Fungicidas para prevenir y controlar patógenos fúngicos | |
| MA28210A1 (fr) | Composition pharmaceutique contenant en association l'ubidecarenone, le dexpanthenol et le chlorhexidine ou leurs sels acceptables du point de vue pharmaceutique pour application cutanee |